120 related articles for article (PubMed ID: 23836507)
1. Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma.
Ortiz-Cuaran S; Cox D; Villar S; Friesen MD; Durand G; Chabrier A; Khuhaprema T; Sangrajrang S; Ognjanovic S; Groopman JD; Hainaut P; Le Calvez-Kelm F
Genes Chromosomes Cancer; 2013 Oct; 52(10):912-9. PubMed ID: 23836507
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
[TBL] [Abstract][Full Text] [Related]
3. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
[TBL] [Abstract][Full Text] [Related]
4. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
5. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
[TBL] [Abstract][Full Text] [Related]
7. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.
Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; Caron de Fromentel C; Chemin IA; Hainaut PL
Carcinogenesis; 2010 Aug; 31(8):1475-82. PubMed ID: 20538734
[TBL] [Abstract][Full Text] [Related]
8. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
Ortiz-Cuaran S; Villar S; Gouas D; Ferro G; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
Cancer Lett; 2013 Apr; 331(1):46-51. PubMed ID: 23200676
[TBL] [Abstract][Full Text] [Related]
9. TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.
Shen T; Li SF; Wang JL; Zhang T; Zhang S; Chen HT; Xiao QY; Ren WH; Liu C; Peng B; Ji XN; Yang Y; Lu PX; Chen TY; Yu L; Ji Y; Jiang DK
Liver Int; 2020 Nov; 40(11):2834-2847. PubMed ID: 32594568
[TBL] [Abstract][Full Text] [Related]
10. Low Frequency of Aflatoxin Induced TP53 Gene Codon 249 Mutation in Hepatocellular Carcinoma from Egyptian Patients Living in the Nile Delta Region.
Mosbeh A; Abdelmaguid W; Ezzat S; Kohla M; Sultan MM; Abdel-Rahman MH
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3165-3168. PubMed ID: 37774068
[TBL] [Abstract][Full Text] [Related]
11. Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
Lino-Silva LS; Lajous M; Brochier M; Santiago-Ruiz L; Melchor-Ruan J; Xie Y; Wang M; Wu D; Higson H; Jones K; Romero-Martínez M; Villalpando S; Mohar A; Smith JW; Alvarez CS; McGlynn KA; Dean M; Groopman J
Salud Publica Mex; 2022 Feb; 64(1):35-40. PubMed ID: 35438902
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.
de Carvalho FM; de Almeida Pereira T; Gonçalves PL; Jarske RD; Pereira FE; Louro ID
Mol Biol Rep; 2013 Aug; 40(8):4883-7. PubMed ID: 23649769
[TBL] [Abstract][Full Text] [Related]
13. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
Gouas D; Shi H; Hainaut P
Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
[TBL] [Abstract][Full Text] [Related]
15. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Woo HG; Wang XW; Budhu A; Kim YH; Kwon SM; Tang ZY; Sun Z; Harris CC; Thorgeirsson SS
Gastroenterology; 2011 Mar; 140(3):1063-70. PubMed ID: 21094160
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.
Han C; Yu T; Qin W; Liao X; Huang J; Liu Z; Yu L; Liu X; Chen Z; Yang C; Wang X; Mo S; Zhu G; Su H; Li J; Qin X; Gui Y; Mo Z; Li L; Peng T
J Gastrointest Oncol; 2020 Dec; 11(6):1333-1349. PubMed ID: 33457005
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
[TBL] [Abstract][Full Text] [Related]
18. Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Long J; Wang Y; Li M; Tong WM; Jia JD; Huang J
Oncol Rep; 2013 Jul; 30(1):119-24. PubMed ID: 23624687
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.
Lleonart ME; Kirk GD; Villar S; Lesi OA; Dasgupta A; Goedert JJ; Mendy M; Hollstein MC; Montesano R; Groopman JD; Hainaut P; Friesen MD
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2956-62. PubMed ID: 16365016
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
